<VariationArchive VariationID="372345" VariationName="NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs)" VariationType="Duplication" Accession="VCV000372345" Version="37" RecordType="classified" NumberOfSubmissions="12" NumberOfSubmitters="12" DateLastUpdated="2024-07-29" DateCreated="2017-01-09" MostRecentSubmission="2024-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="359567" VariationID="372345">
      <GeneList>
        <Gene Symbol="COL7A1" FullName="collagen type VII alpha 1 chain" GeneID="1294" HGNC_ID="HGNC:2214" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48564073" stop="48595329" display_start="48564073" display_stop="48595329" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48601505" stop="48632592" display_start="48601505" display_stop="48632592" Strand="-" />
          </Location>
          <OMIM>120120</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs)</Name>
      <CanonicalSPDI>NC_000003.12:48573864:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48573864" stop="48573865" display_start="48573864" display_stop="48573865" variantLength="1" positionVCF="48573864" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48611297" stop="48611298" display_start="48611297" display_stop="48611298" variantLength="1" positionVCF="48611297" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>G2177fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.48611303dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.48611303dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.48573870dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.48573870dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007065.1" sequenceAccession="NG_007065" sequenceVersion="1" change="g.26388dup">
            <Expression>NG_007065.1:g.26388dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.4" sequenceAccession="NM_000094" sequenceVersion="4" change="c.6527dup" MANESelect="true">
            <Expression>NM_000094.4:c.6527dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000085.1" sequenceAccession="NP_000085" sequenceVersion="1" change="p.Gly2177fs">
            <Expression>NP_000085.1:p.Gly2177fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.4" sequenceAccession="NM_000094" sequenceVersion="4" change="c.6527dupC" MANESelect="true">
            <Expression>NM_000094.4:c.6527dupC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.3" sequenceAccession="NM_000094" sequenceVersion="3" change="c.6527dupC">
            <Expression>NM_000094.3:c.6527dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_286" sequenceAccession="LRG_286">
            <Expression>LRG_286:g.26388dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_286t1" sequenceAccession="LRG_286t1">
            <Expression>LRG_286t1:c.6527dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_286p1" sequenceAccession="LRG_286p1" change="p.Gly2177fs">
            <Expression>LRG_286p1:p.Gly2177fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="768128088" DB="dbSNP" />
        <XRef ID="CA2378969" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs) AND not provided" Accession="RCV000413123" Version="10">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-24" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs) AND Recessive dystrophic epidermolysis bullosa" Accession="RCV000454227" Version="4">
        <ClassifiedConditionList TraitSetID="5728">
          <ClassifiedCondition DB="MedGen" ID="C0079474">Recessive dystrophic epidermolysis bullosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-03-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs) AND Inborn genetic diseases" Accession="RCV001266180" Version="4">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-03-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs) AND Epidermolysis bullosa dystrophica inversa, autosomal recessive" Accession="RCV001272346" Version="3">
        <ClassifiedConditionList TraitSetID="5738">
          <ClassifiedCondition DB="MedGen" ID="C2673612">Epidermolysis bullosa dystrophica inversa, autosomal recessive</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs) AND Epidermolysis bullosa dystrophica" Accession="RCV001352936" Version="3">
        <ClassifiedConditionList TraitSetID="8897">
          <ClassifiedCondition DB="MedGen" ID="C0079294">Epidermolysis bullosa dystrophica</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs) AND See cases" Accession="RCV003156091" Version="2">
        <ClassifiedConditionList TraitSetID="16994">
          <ClassifiedCondition>See cases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs) AND multiple conditions" Accession="RCV002502441" Version="2">
        <ClassifiedConditionList TraitSetID="11604">
          <ClassifiedCondition DB="MedGen" ID="C0268371">Dominant dystrophic epidermolysis bullosa with absence of skin</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1275114">Epidermolysis bullosa pruriginosa</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0432322">Generalized dominant dystrophic epidermolysis bullosa</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1843761">Nonsyndromic congenital nail disorder 8</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0432321">Pretibial dystrophic epidermolysis bullosa</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0079474">Recessive dystrophic epidermolysis bullosa</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1851573">Transient bullous dermolysis of the newborn</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs) AND multiple conditions" Accession="RCV002244860" Version="3">
        <ClassifiedConditionList TraitSetID="22019">
          <ClassifiedCondition DB="MedGen" ID="C0432322">Generalized dominant dystrophic epidermolysis bullosa</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0079474">Recessive dystrophic epidermolysis bullosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs) AND COL7A1-related disorder" Accession="RCV003972555" Version="2">
        <ClassifiedConditionList TraitSetID="89973">
          <ClassifiedCondition>COL7A1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-16" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-16" NumberOfSubmissions="12" NumberOfSubmitters="12" DateCreated="2017-01-09" MostRecentSubmission="2024-04-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16971478</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20920254</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23947675</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35979658</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9326325</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8897" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9485" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dystrophic epidermolysis bullosa, Hallopeau-Siemens type (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="Dystrophic+Epidermolysis+Bullosa/2423" DB="Genetic Alliance" />
                <XRef ID="254185007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa dystrophica</ElementValue>
                <XRef ID="MONDO:0006543" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2150" />
                <XRef ID="2150" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="303" DB="Orphanet" />
              <XRef ID="C0079294" DB="MedGen" />
              <XRef ID="MONDO:0006543" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="16994" Type="PhenotypeInstruction" ContributesToAggregateClassification="true">
            <Trait ID="18728" Type="PhenotypeInstruction">
              <Name>
                <ElementValue Type="Preferred">See cases</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="5728" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1160" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hallopeau-Siemens Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">severe generalized recessive dystrophic epidermolysis bullosa</ElementValue>
                <Citation Type="general">
                  <ID Source="PubMed">18374450</ID>
                </Citation>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Distrophica Autosomal Recessive (RDEB)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0025" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0038" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0024" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0023" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0037" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0034" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0036" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Recessive dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="Recessive+dystrophic+epidermolysis+bullosa/9208" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009179" DB="MONDO" />
                <XRef ID="48528004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EBR1</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">RDEB</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6308" />
                <XRef ID="6308" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="79408" DB="Orphanet" />
              <XRef ID="79409" DB="Orphanet" />
              <XRef ID="C0079474" DB="MedGen" />
              <XRef ID="MONDO:0009179" DB="MONDO" />
              <XRef Type="MIM" ID="226600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5738" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="8933" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa dystrophica inversa, autosomal recessive</ElementValue>
              </Name>
              <XRef ID="C2673612" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="22019" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14025" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Generalized dominant dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="MONDO:0007549" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DDEB, generalized</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DDEB-gen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="131750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa dystrophica, autosomal dominant</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EBDD</ElementValue>
                <XRef Type="MIM" ID="131750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DDEB</ElementValue>
                <XRef Type="MIM" ID="131750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2139" />
                <XRef ID="2139" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="231568" DB="Orphanet" />
              <XRef ID="C0432322" DB="MedGen" />
              <XRef ID="MONDO:0007549" DB="MONDO" />
              <XRef Type="MIM" ID="131750" DB="OMIM" />
            </Trait>
            <Trait ID="1160" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hallopeau-Siemens Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">severe generalized recessive dystrophic epidermolysis bullosa</ElementValue>
                <Citation Type="general">
                  <ID Source="PubMed">18374450</ID>
                </Citation>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Distrophica Autosomal Recessive (RDEB)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0025" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0038" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0024" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0023" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0037" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0034" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0036" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Recessive dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="Recessive+dystrophic+epidermolysis+bullosa/9208" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009179" DB="MONDO" />
                <XRef ID="48528004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EBR1</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">RDEB</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6308" />
                <XRef ID="6308" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="79408" DB="Orphanet" />
              <XRef ID="79409" DB="Orphanet" />
              <XRef ID="C0079474" DB="MedGen" />
              <XRef ID="MONDO:0009179" DB="MONDO" />
              <XRef Type="MIM" ID="226600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="11604" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1599" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL</ElementValue>
                <XRef Type="MIM" ID="131850" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pretibial dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="MONDO:0007552" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pretibial epidermolysis bullosa</ElementValue>
                <XRef ID="HP:0012221" DB="Human Phenotype Ontology" />
                <XRef ID="67653003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pretibial blistering</ElementValue>
                <XRef ID="HP:0012221" DB="Human Phenotype Ontology" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2155" />
                <XRef ID="2155" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="79410" DB="Orphanet" />
              <XRef ID="C0432321" DB="MedGen" />
              <XRef ID="MONDO:0007552" DB="MONDO" />
              <XRef Type="MIM" ID="131850" DB="OMIM" />
              <XRef Type="primary" ID="HP:0012221" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="1603" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dominant dystrophic epidermolysis bullosa with absence of skin</ElementValue>
                <XRef ID="2689001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS</ElementValue>
                <XRef Type="MIM" ID="132000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, BART TYPE</ElementValue>
                <XRef Type="MIM" ID="132000" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0008" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="C0268371" DB="MedGen" />
              <XRef ID="MONDO:0007557" DB="MONDO" />
              <XRef Type="MIM" ID="132000" DB="OMIM" />
            </Trait>
            <Trait ID="6060" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nonsyndromic congenital nail disorder 8</ElementValue>
                <XRef ID="MONDO:0011852" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TOENAIL DYSTROPHY, ISOLATED</ElementValue>
                <XRef Type="MIM" ID="607523" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NDNC8</ElementValue>
                <XRef Type="MIM" ID="607523" DB="OMIM" />
              </Symbol>
              <XRef ID="C1843761" DB="MedGen" />
              <XRef ID="MONDO:0011852" DB="MONDO" />
              <XRef Type="MIM" ID="607523" DB="OMIM" />
            </Trait>
            <Trait ID="4289" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa dystrophica, dominant neonatal form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Transient bullous dermolysis of the newborn</ElementValue>
                <XRef ID="Transient+bullous+dermolysis+of+the+newborn/7164" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007548" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, NEONATAL</ElementValue>
                <XRef Type="MIM" ID="131705" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, NEONATAL FORM</ElementValue>
                <XRef Type="MIM" ID="131705" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TBDN</ElementValue>
                <XRef Type="MIM" ID="131705" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10010" />
                <XRef ID="10010" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="79411" DB="Orphanet" />
              <XRef ID="C1851573" DB="MedGen" />
              <XRef ID="MONDO:0007548" DB="MONDO" />
              <XRef Type="MIM" ID="131705" DB="OMIM" />
            </Trait>
            <Trait ID="5019" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa pruriginosa</ElementValue>
                <XRef ID="Epidermolysis+bullosa+pruriginosa/8317" DB="Genetic Alliance" />
                <XRef ID="403810008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DEB, PRURIGINOSA</ElementValue>
                <XRef Type="MIM" ID="604129" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA PRURIGINOSA</ElementValue>
                <XRef Type="MIM" ID="604129" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16779" />
                <XRef ID="16779" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="89843" DB="Orphanet" />
              <XRef ID="C1275114" DB="MedGen" />
              <XRef ID="MONDO:0011398" DB="MONDO" />
              <XRef Type="MIM" ID="604129" DB="OMIM" />
            </Trait>
            <Trait ID="14025" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Generalized dominant dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="MONDO:0007549" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DDEB, generalized</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DDEB-gen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="131750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa dystrophica, autosomal dominant</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EBDD</ElementValue>
                <XRef Type="MIM" ID="131750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DDEB</ElementValue>
                <XRef Type="MIM" ID="131750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2139" />
                <XRef ID="2139" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="231568" DB="Orphanet" />
              <XRef ID="C0432322" DB="MedGen" />
              <XRef ID="MONDO:0007549" DB="MONDO" />
              <XRef Type="MIM" ID="131750" DB="OMIM" />
            </Trait>
            <Trait ID="1160" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hallopeau-Siemens Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">severe generalized recessive dystrophic epidermolysis bullosa</ElementValue>
                <Citation Type="general">
                  <ID Source="PubMed">18374450</ID>
                </Citation>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Distrophica Autosomal Recessive (RDEB)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0025" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0038" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0024" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0023" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0037" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0034" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0036" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Recessive dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="Recessive+dystrophic+epidermolysis+bullosa/9208" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009179" DB="MONDO" />
                <XRef ID="48528004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EBR1</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">RDEB</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6308" />
                <XRef ID="6308" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="79408" DB="Orphanet" />
              <XRef ID="79409" DB="Orphanet" />
              <XRef ID="C0079474" DB="MedGen" />
              <XRef ID="MONDO:0009179" DB="MONDO" />
              <XRef Type="MIM" ID="226600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89973" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69901" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">COL7A1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">COL7A1-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COL7A1- related disorders</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1048730" SubmissionDate="2016-08-10" DateLastUpdated="2017-04-03" DateCreated="2017-04-03">
        <ClinVarSubmissionID localKey="2016_11|OMIM:226600" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000538019" DateUpdated="2017-04-03" DateCreated="2017-04-03" Type="SCV" Version="1" SubmitterName="Knight Diagnostic Laboratories, Oregon Health and Sciences University" OrgID="505542" OrganizationCategory="laboratory" OrgAbbreviation="KDL-OHSU" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-12-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.6527dupC (p.Gly2177Trpfs*113) frameshift variant in the COL7A1 gene has been previously reported in at least 27 affected individuals with autosomal recessive Dystrophic Epidermolysis Bullosa and is predicted to prematurely truncate the protein. Affected individuals have harbored this frameshift variant in trans with a splice-site variant (7930-1G&gt;C) and several missense variants (G2587D, G2434R, G2366D, G1383R) (Hovnanian et al., 1997; Cuadrado-Corrales et al., 2010; Kern et al. 2006). Loss of functions variants have been described in the COL7A1 gene in several affected individuals (OMIM#: 120120) and are, therefore, a common mechanism of disease. Functional studies have shown gene and protein expression are not detectable when this variant is present (Hovnanian et al., 1997; Cuadrado-Corrales et al., 2010).This c.6527dupC variant is absent from two control population databases (Exome Sequencing Project [ESP] and 1000 Genomes) and present at a low frequency in a third control population database (ExAC = 0.044%). In silico algorithms predict the nucleotide position where this variant occurs is conserved (GERP = 4.53). Therefore, this collective evidence supports the classification of the c.6527dupC (p.Gly2177Trpfs*113) as a recessive Pathogenic variant for Dystrophic Epidermolysis Bullosa.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.6527dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226600" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-NextGen</StudyName>
        <SubmissionNameList>
          <SubmissionName>CSER-NextGen-1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2869532" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_000094.3:c.6527dupC|Autosomal recessive epidermolysis bullosa dystrophica inversa" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001454257" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.6527dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Autosomal recessive epidermolysis bullosa dystrophica inversa</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2852441" SubmissionDate="2020-10-09" DateLastUpdated="2023-01-07" DateCreated="2020-11-21">
        <ClinVarSubmissionID localKey="a8664039" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001444352" DateUpdated="2023-01-07" DateCreated="2020-11-21" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-03-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9326325</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20920254</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23947675</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry exome assertion method (8-5-2015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/xlwdlsvu/ambry_exome_assertion_method_8-5-2015_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Caucasian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <FamilyData PedigreeID="a739754" />
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormal blistering of the skin</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0008066" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Dystrophic fingernails</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0008391" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Dystrophic toenail</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001810" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.6527dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MeSH" ID="D030342" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="957969" SubmissionDate="2021-12-08" DateLastUpdated="2023-03-04" DateCreated="2017-01-09">
        <ClinVarSubmissionID localKey="GDXSV:216410" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000490503" DateUpdated="2023-03-04" DateCreated="2017-01-09" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 16971478, 21448560, 31001817, 9326325, 20920254, 23947675, 28973459, 31589614, 29242947, 20184583, 29272047)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:15590</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.6527dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_62_20211022152658</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_74_20211208054205</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1835997" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-13">
        <ClinVarSubmissionID localKey="3637001|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000942042" DateUpdated="2024-02-14" DateCreated="2019-08-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16971478</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9326325</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20920254</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9326325</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20920254</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly2177Trpfs*113) in the COL7A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL7A1 are known to be pathogenic (PMID: 16971478). This variant is present in population databases (rs768128088, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with autosomal recessive dystrophic epidermolysis bullosa (PMID: 9326325, 20920254). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It is commonly reported in individuals of Spanish ancestry (PMID: 9326325, 20920254). ClinVar contains an entry for this variant (Variation ID: 372345). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.48611297_48611298insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3047348" SubmissionDate="2021-03-10" DateLastUpdated="2021-03-28" DateCreated="2021-03-28">
        <ClinVarSubmissionID localKey="NM_000094.4:c.6527dupC|Dystrophic epidermolysis bullosa" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001547559" DateUpdated="2021-03-28" DateCreated="2021-03-28" Type="SCV" Version="1" SubmitterName="Biomedical Innovation Departament, CIEMAT" OrgID="506581" OrganizationCategory="resource" OrgAbbreviation="BioINN" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9326325</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="74" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Gly2177Trpfs*113</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.4:c.6527dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Dystrophic epidermolysis bullosa</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9248696</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4889040" SubmissionDate="2022-04-12" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="NM_000094.3:c.6527dup|OMIM:226600" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002499306" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="Center for Research in Genodermatoses and Epidermolysis Bullosa, University of Buenos Aires" OrgID="508489" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">35979658</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="19" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Sanger Sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="19" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="3" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="16" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <Citation>
              <ID Source="PubMed">9326325</ID>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.6527dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226600" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">35979658</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11321124</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4924389" SubmissionDate="2022-05-11" DateLastUpdated="2022-05-21" DateCreated="2022-05-21">
        <ClinVarSubmissionID localKey="NM_000094.4:c.6527dup|OMIM:131750;226600" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002512618" DateUpdated="2022-05-21" DateCreated="2022-05-21" Type="SCV" Version="1" SubmitterName="Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein" OrgID="508506" OrganizationCategory="laboratory" OrgAbbreviation="LABO-HIAE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG classification criteria: PVS1 very strong, PS3 supporting, PS4 strong, PM2 moderate, PM3 very strong, PM3 moderate</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.4:c.6527dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="131750" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226600" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11461911</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5460041" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000094.4:c.6527dup|OMIM:131705;131750;131850;132000;226600;604129;607523" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002811111" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.4:c.6527dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="131705" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="131750" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="131850" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="132000" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226600" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604129" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607523" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7184551" SubmissionDate="2023-03-22" DateLastUpdated="2023-04-01" DateCreated="2023-04-01">
        <ClinVarSubmissionID localKey="NM_000094.3:c.6527dupC|See cases" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003845225" DateUpdated="2023-04-01" DateCreated="2023-04-01" Type="SCV" Version="1" SubmitterName="Center for Personalized Medicine, Children's Hospital Los Angeles" OrgID="506200" OrganizationCategory="laboratory" OrgAbbreviation="CPM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0008066" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0011830" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0008404" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0200097" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.6527dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="PhenotypeInstruction">
          <Trait Type="PhenotypeInstruction">
            <Name>
              <ElementValue Type="Preferred">See cases</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12975518</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8875020" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="5932775|COL7A1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004788168" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The COL7A1 c.6527dupC variant is predicted to result in a frameshift and premature protein termination (p.Gly2177Trpfs*113). This variant has been reported in the homozygous or compound heterozygous state in multiple unrelated individuals with epidermolysis bullosa dystrophica (see for example - referred to as 6527insC in Hovnanian et al. 1997. PubMed ID: 9326325; Cuadrado-Corrales et al. 2010. PubMed ID: 20920254; Almaani et al. 2011. PubMed ID: 21448560). This variant is reported in 0.043% of alleles in individuals of Latino descent in gnomAD. Frameshift variants in COL7A1 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.6527dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COL7A1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8998839" SubmissionDate="2024-04-03" DateLastUpdated="2024-04-15" DateCreated="2024-04-15">
        <ClinVarSubmissionID localKey="NM_000094.4:c.6527dupC|COL7A1-Related Disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004813109" DateUpdated="2024-04-15" DateCreated="2024-04-15" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20920254</ID>
          </Citation>
          <Comment>Variant summary: COL7A1 c.6527dupC (p.Gly2177TrpfsX113) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 6.8e-05 in 250676 control chromosomes. c.6527dupC has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Dystrophic Epidermolysis Bullosa, Recessive with the variant described as a founder mutation of Spanish origin (e.g. Cuadrado-Corrales_2010). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 20920254). ClinVar contains an entry for this variant (Variation ID: 372345). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.4:c.6527dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COL7A1-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14342304</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7184551" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008404" MappingRef="HP">
        <MedGen CUI="C0221260" Name="Nail dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5460041" TraitType="Disease" MappingType="XRef" MappingValue="131750" MappingRef="OMIM">
        <MedGen CUI="C0432322" Name="Generalized dominant dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5460041" TraitType="Disease" MappingType="XRef" MappingValue="607523" MappingRef="OMIM">
        <MedGen CUI="C1843761" Name="Nonsyndromic congenital nail disorder 8" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8875020" TraitType="Disease" MappingType="Name" MappingValue="COL7A1-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="COL7A1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="957969" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2852441" TraitType="Finding" MappingType="Name" MappingValue="Abnormal blistering of the skin" MappingRef="Preferred">
        <MedGen CUI="C2132198" Name="Abnormal blistering of the skin" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4889040" TraitType="Disease" MappingType="XRef" MappingValue="226600" MappingRef="OMIM">
        <MedGen CUI="C0079474" Name="Recessive dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5460041" TraitType="Disease" MappingType="XRef" MappingValue="131850" MappingRef="OMIM">
        <MedGen CUI="C0432321" Name="Pretibial dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1835997" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8998839" TraitType="Disease" MappingType="Name" MappingValue="COL7A1-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="COL7A1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5460041" TraitType="Disease" MappingType="XRef" MappingValue="604129" MappingRef="OMIM">
        <MedGen CUI="C1275114" Name="Epidermolysis bullosa pruriginosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2852441" TraitType="Finding" MappingType="Name" MappingValue="Dystrophic fingernails" MappingRef="Preferred">
        <MedGen CUI="C3551426" Name="Dystrophic fingernails" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3047348" TraitType="Disease" MappingType="Name" MappingValue="Dystrophic epidermolysis bullosa" MappingRef="Preferred">
        <MedGen CUI="C0079294" Name="Epidermolysis bullosa dystrophica" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4924389" TraitType="Disease" MappingType="XRef" MappingValue="226600" MappingRef="OMIM">
        <MedGen CUI="C0079474" Name="Recessive dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1048730" TraitType="Disease" MappingType="XRef" MappingValue="226600" MappingRef="OMIM">
        <MedGen CUI="C0079474" Name="Recessive dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2869532" TraitType="Disease" MappingType="Name" MappingValue="Autosomal recessive epidermolysis bullosa dystrophica inversa" MappingRef="Preferred">
        <MedGen CUI="C2673612" Name="Epidermolysis bullosa dystrophica inversa, autosomal recessive" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7184551" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011830" MappingRef="HP">
        <MedGen CUI="C4023170" Name="Abnormal oral mucosa morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7184551" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008066" MappingRef="HP">
        <MedGen CUI="C2132198" Name="Abnormal blistering of the skin" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2852441" TraitType="Finding" MappingType="Name" MappingValue="Dystrophic toenail" MappingRef="Preferred">
        <MedGen CUI="C1833225" Name="Dystrophic toenail" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7184551" TraitType="Finding" MappingType="XRef" MappingValue="HP:0200097" MappingRef="HP">
        <MedGen CUI="C0853945" Name="Oral mucosal blisters" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5460041" TraitType="Disease" MappingType="XRef" MappingValue="132000" MappingRef="OMIM">
        <MedGen CUI="C0268371" Name="Dominant dystrophic epidermolysis bullosa with absence of skin" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2852441" TraitType="Disease" MappingType="XRef" MappingValue="D030342" MappingRef="MeSH">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4924389" TraitType="Disease" MappingType="XRef" MappingValue="131750" MappingRef="OMIM">
        <MedGen CUI="C0432322" Name="Generalized dominant dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5460041" TraitType="Disease" MappingType="XRef" MappingValue="226600" MappingRef="OMIM">
        <MedGen CUI="C0079474" Name="Recessive dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5460041" TraitType="Disease" MappingType="XRef" MappingValue="131705" MappingRef="OMIM">
        <MedGen CUI="C1851573" Name="Transient bullous dermolysis of the newborn" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7184551" TraitType="PhenotypeInstruction" MappingType="Name" MappingValue="See cases" MappingRef="Preferred">
        <MedGen CUI="None" Name="See cases" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

